Clinical trials have shown tirzepatide producing greater average weight loss than semaglutide approximately 20-22% total body weight versus 15% though both represent significant advances in pharmacological weight management
Took a GLP-1 Drug (name brand drug / not compound version) manufactured by Novo Nordisk or Elli Lilly: (Evidence is required that you had an Ozempic script or a prescription from other qualifying GLP-1 medication
This is normal thermodynamics, not medication failure
When the science is this nuanced, having a trusted resource behind every decision matters more than most people realize
All GLP-1 receptor agonists cause similar modest heart rate increases of approximately 24 beats per minute on average, including liraglutide, semaglutide, dulaglutide, and tirzepatide
And if your insurance covers Wegovy, some patients may pay as little as ~$25/month depending on their plan and eligibility